Thursday, June 5, 2025
VISIT ROYALMOK
Agarwood Times
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
Agarwood Times
No Result
View All Result

Peptilogics receives $3.3 million from CARB-X to develop treatment for fracture-related infections

January 12, 2025
in Diseases
Reading Time: 2 mins read
0 0
A A
0
Home Diseases
Share on FacebookShare on Twitter


Antibiotic development
unoL / iStock

CARB-X (Combating Antibiotic-Resistant Micro organism Biopharmaceutical Accelerator) yesterday introduced an award of $3.3 million to Pittsburgh-based Peptilogics to develop a slow-release model of its investigational, broad-spectrum therapeutic for joint-related infections.

The funding will assist Peptilogics develop and execute a workplan for zaloganan-CR, a controlled-release formulation of the anti-bacterial and anti-biofilm peptide the corporate is creating for prosthetic joint infections. Zaloganan, which was supported by a CARB-X award in 2020 and is presently in section 1 medical trials, works by concentrating on and disrupting bacterial membranes and has demonstrated broad-spectrum exercise in opposition to a variety of pathogens.

The brand new award goals to increase the usage of zaloganan to stop infections in open fractures, lacerations, and burns, which will be biofilm-based and resistant to plain antibiotics and ultimately become extra critical bloodstream infections.

“Peptilogics’ growth of zaloganan-CR provides the potential for a promising resolution to fight fracture-related infections, that are a number one consider affected person issues and rising healthcare bills,” Erin Duffy, PhD, chief of analysis and growth (R&D) at CARB-X, stated in a press launch. “With its broad-spectrum exercise and focused supply, zaloganan-CR has the potential to rework an infection prevention in high-trauma accidents.”

A ‘staggeringly massive’ downside

Firm officers say zaloganan-CR has the potential to cut back the long-term medical and financial impression of fracture-related infections (FRIs), that are a selected problem in low- and middle-income international locations.

“This extra funding permits us to speed up our prevention program by addressing bloodstream an infection linked to FRI, which continues to be a staggeringly massive downside in surgical affected person care,” stated Peptilogics CEO Jonathan Steckbeck, PhD. “By tackling this downside, we won’t solely be advancing the science of an infection prevention but additionally pave the way in which to ship a brand new era of breakthrough merchandise to sufferers in want.”

Since its founding in 2016, CARB-X has supported 106 early-stage antibiotic, diagnostic, and vaccine initiatives in 13 international locations.



Source link

Tags: CARBXdevelopfracturerelatedinfectionsMillionPeptilogicsreceivesTreatment
Previous Post

Study: RSV in preschoolers comes with significant healthcare use, parents’ work absence

Next Post

Polio cases reported in 3 countries

Related Posts

Discovery of distinct pathway for chronic pain opens door to new treatments
Diseases

Discovery of distinct pathway for chronic pain opens door to new treatments

June 5, 2025
Baby’s microbiome may protect against later childhood viral infection
Diseases

Baby’s microbiome may protect against later childhood viral infection

June 5, 2025
Maternal obesity linked to increase in childhood infections
Diseases

Maternal obesity linked to increase in childhood infections

June 5, 2025
‘Helping people survive’: how creating a hip-hop album saved incarcerated artists | Hip-hop
Diseases

‘Helping people survive’: how creating a hip-hop album saved incarcerated artists | Hip-hop

June 4, 2025
Mother’s obesity linked to child’s heightened hospital admission risk for infection
Diseases

Mother’s obesity linked to child’s heightened hospital admission risk for infection

June 4, 2025
Report highlights evidence, remaining data gaps on vaccines and antibiotic resistance
Diseases

Report highlights evidence, remaining data gaps on vaccines and antibiotic resistance

June 3, 2025
Next Post
Polio cases reported in 3 countries

Polio cases reported in 3 countries

Avian flu strikes more US poultry on East Coast and in Midwest

Avian flu strikes more US poultry on East Coast and in Midwest

5 Ways the Healthcare Industry Should Improve Youth Mental Health, Per BPC’s Task Force

5 Ways the Healthcare Industry Should Improve Youth Mental Health, Per BPC’s Task Force

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Kura Oncology Drug’s Data at ASCO Support FDA Filing Now Under Priority Review for Leukemia
Health

Kura Oncology Drug’s Data at ASCO Support FDA Filing Now Under Priority Review for Leukemia

by admin
June 4, 2025
0

A Kura Oncology and Kyowa Kirin-partnered drug vying to grow to be the primary FDA-approved remedy for instances of acute...

One negative take

One negative take

June 5, 2025
Portal Access secures M for chemotherapy port

Portal Access secures $7M for chemotherapy port

May 31, 2025
AstraZeneca, Genentech, Roche, Takeda Day 3 news

AstraZeneca, Genentech, Roche, Takeda Day 3 news

June 2, 2025
Fine particulate matter exposure may alter pregnancy outcomes

Fine particulate matter exposure may alter pregnancy outcomes

June 3, 2025
This Wood is More Valuable than Gold 🤯 (Agarwood)

This Wood is More Valuable than Gold 🤯 (Agarwood)

June 4, 2025
Facebook Twitter Instagram Youtube RSS
Agarwood Times

Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.

CATEGORIES

  • Agarwood
  • Diet & Fitness
  • Diseases
  • Health
  • Meditation
  • Nutrition
  • Sleep Info
  • Uncategorized
No Result
View All Result

SITEMAP

  • About us
  • Advertise With Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
VISIT ROYALMOK

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In